Contrast agent for magnetic resonance angiography: experimental evaluation of superparamagnetic iron oxide composed of polysaccharide complex involving chondroitinsulfuric acid.
Yoshikawa
K
K
Department of Radiology, Institute of Medical Science, University of Tokyo, Japan.
Yagi
K
K
Nanjo
S
S
Seno
A
A
Shiono
T
T
Tobe
K
K
Suzuki
S
S
D000818:Animals; D002809:Chondroitin Sulfates / Q000493:pharmacokinetics; D003287:Contrast Media / Q000737:chemistry; D005290:Ferric Compounds / Q000493:pharmacokinetics; D019786:Gadolinium DTPA; D007275:Injections, Intravenous; D007501:Iron / Q000493:pharmacokinetics; D008279:Magnetic Resonance Imaging; D008297:Male; D009942:Organometallic Compounds / Q000493:pharmacokinetics; D010087:Oxides / Q000493:pharmacokinetics; D004369:Pentetic Acid / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D011134:Polysaccharides / Q000493:pharmacokinetics; D051381:Rats; D013329:Structure-Activity Relationship
D003287:Contrast Media; D005290:Ferric Compounds; D009942:Organometallic Compounds; D010087:Oxides; D011134:Polysaccharides; C000499:ferric oxide; D004369:Pentetic Acid; D002809:Chondroitin Sulfates; D007501:Iron; D019786:Gadolinium DTPA